Avadel Pharmaceuticals plc (AVDL) Financial Analysis & Valuation | Quarter Chart
Avadel Pharmaceuticals plc (AVDL)
AVDLPrice: $21.64
Fair Value: 🔒
🔒score
Description
Shares
| Market Cap | $2.12B | Exchange | NASDAQ |
| Sector | — | Industry | — |
| Country | — | CEO | Gregory J. Divis Jr. |
| IPO Date | 1996-06-07 | CAGR | 0.13% |
| Employees | 188 | Website | — |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
AVDL chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.44B | P/E Ratio | -934.5 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 8.55 | P/B Ratio | 21.39 |
| P/CF Ratio | 59.03 | P/FCF Ratio | 59.99 |
| EPS | $-0.02 | EPS Growth 1Y | -100.02% |
| EPS Growth 3Y | -100.01% | EPS Growth 5Y | -99.9% |
| Revenue Growth 1Y | 79.88% | Gross Margin | 0.94% |
| Operating Margin | 0.02% | Profit Margin | -0% |
| ROE | — | ROA | — |
| ROCE | 0.03% | Current Ratio | 2.76 |
| Quick Ratio | 2.37 | Cash Ratio | 1.28 |
| Debt/Equity | 0.38 | Interest Coverage | 0.47 |
| Altman Z Score | 9.06 | Piotroski Score | 4 |